Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery.

Autor: Mehl, Julian1 (AUTHOR) julian.mehl@students.unibe.ch, Akhoundova, Dilara1 (AUTHOR) dilara.akhoundovasanoyan@insel.ch, Bacher, Ulrike2 (AUTHOR) veraulrike.bacher@insel.ch, Jeker, Barbara1 (AUTHOR) barbara.jeker@insel.ch, Rhyner Agocs, Gaëlle3 (AUTHOR) gaelle.rhyner@h-fr.ch, Ruefer, Axel4 (AUTHOR) axel.ruefer@luks.ch, Soltermann, Susanne5 (AUTHOR) susanne.soltermann@spital.so.ch, Soekler, Martin6 (AUTHOR) martin.soekler@spitalstsag.ch, Winkler, Annette7 (AUTHOR) annette.winkler@spitalzentrum-biel.ch, Daskalakis, Michael2 (AUTHOR) michael.daskalakis@insel.ch, Pabst, Thomas1 (AUTHOR) thomas.pabst@insel.ch
Zdroj: Cancers. May2024, Vol. 16 Issue 10, p1854. 15p.
Databáze: Academic Search Ultimate